Please login to the form below

Not currently logged in
Email:
Password:

edivoxetine

This page shows the latest edivoxetine news and features for those working in and with pharma, biotech and healthcare.

Lilly drops tabalumab after lupus joins arthritis on failure list

Lilly drops tabalumab after lupus joins arthritis on failure list

The latest setback marks a barren spell for Lilly in bringing new products to market in the last few years, with a number of late-stage failure including edivoxetine for depression,

Latest news

  • Lilly's stomach cancer drug cleared by FDA Lilly's stomach cancer drug cleared by FDA

    The cancer portfolio is a bright spot for Lilly, which has been plagued by a series of late-stage pipeline failures in the last couple of years, including edivoxetine for depression,

  • Lilly/Boehringer's empagliflozin faces US approval delay Lilly/Boehringer's empagliflozin faces US approval delay

    last year it suffered late-stage setbacks with antidepressant edivoxetine, enzastaurin for lymphoma and tabalumab for rheumatoid arthritis.

  • Lilly feels effects of Cymbalta competition Lilly feels effects of Cymbalta competition

    Cymbalta follow-up edivoxetine failed to meet its objectives in phase III trials as an adjunctive therapy for major depression towards the end of last year and has been discontinued, while

  • Moving parts Moving parts

    Meanwhile, costly phase III failures arrived in the shape of Lilly's depression drug edivoxetine and GlaxoSmithKline's highly anticipated new coronary heart disease drug candidate darapladib, which both flunked

  • First Cymbalta generics approved in the US First Cymbalta generics approved in the US

    cliff. It suffered a major setback in its pipeline earlier this month however when Cymbalta follow-up edivoxetine failed to meet the primary objectives of three late-stage studies.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics